Business Wire

‘Playtime is Over’ for GenAI: NTT DATA Research Shows Organizations Shifting From Experiments to Investments That Drive Performance

14.11.2024 16:27:00 EET | Business Wire | Press release

Share

NTT DATA, a global digital business and IT services leader, today released the first results of its extensive original research that reveals “playtime is over” for GenAI. The results overwhelmingly found that leaders are turning their focus from experimentation to long-term use cases that transform business performance, workplace culture, compliance, safety and sustainability.

The study, “Global GenAI Report: How organizations are mastering their GenAI destiny in 2025,” found that almost all leaders surveyed already have invested in GenAI, and 83% have established “expert” or “robust” GenAI teams. Top use cases for GenAI include:

  • Personalized service recommendations and knowledge management
  • Quality control
  • Research and Development (R&D)

“The future is clear. Generative AI is more than just another tool – it’s a transformative force,” said Yutaka Sasaki, President and Chief Executive Officer, NTT DATA Group. “As we move beyond experimentation, a tension emerges: move too fast, and we risk unintended circumstances; move too slow and we fall behind. Getting GenAI right isn’t optional. That’s why we’re providing a blueprint to help our clients harness its potential for lasting success.”

Two-thirds of C-suite respondents said GenAI will be a “game changer” over the next two years and will improve:

  • Productivity and efficiency
  • Sustainability
  • Compliance
  • Business processes
  • Security
  • Employee experience

Strategy and Transformation

  • A cycle of consolidation and integration of GenAI technologies is beginning that combines experimental, phased and specific approaches. Focused spending plans will replace scattered experimentation in a relatively short time:
  • 97% of CEOs anticipate a material impact from this technology.
  • 70% of CEOs expect significant transformation in 2025.
  • 83% of respondents said they have a well-defined GenAI strategy in place, but 51% have not yet aligned that strategy with their business plans. This gap limits return on investment and satisfaction with current outcomes.

Innovation and Technology

Nearly all respondents agree GenAI can spark creativity and improve R&D activities. Given the rapid adoption and advancement of GenAI technology, organizations will have to constantly re-evaluate and evolve their strategies and operating models. Key findings:

  • 90% said legacy infrastructure hinders effective use of GenAI.
  • 96% of CIOs and CTOs said cloud-based solutions are the most practical method for supporting GenAI applications.

People and Culture

96% of respondents are considering how GenAI can streamline future employee workflows and support processes. However, 67% of respondents said their employees lack the necessary skills to work with GenAI. About half are planning employee education and training to increase GenAI adoption.

The top obstacles to adoption are:

  • Users who perceive limited value for a GenAI solution
  • Limited or no awareness of the solution
  • User resistance to the technology
  • Concerns about GenAI’s safety and security

Ethics, Safety and Sustainability

As GenAI infuses into daily life, balancing responsibility and innovation will be a moral imperative as well as a strategic necessity for leaders, organizations and society as a whole. Leaders largely recognize a mandate to strike this balance. Specifically:

  • 81% said it’s “very important” for leaders to help employees balance innovation and responsibility.
  • 72% said their organization lacks a GenAI usage policy for employees, including guidance on protecting intellectual property.
  • 45% of CISOs expressed concerns about the technology, saying they feel “pressured, threatened or overwhelmed.”
  • 82% said government regulations on AI are unclear, which hinders GenAI strategies, and most respondents expect spending on GenAI-related regulatory compliance will increase.

Despite significant challenges, 68% of respondents globally said they feel “excited” and “amazed” about GenAI’s transformative potential.

“This is a powerful point in world history as GenAI is shaping up to be a huge force in our tech-enabled economy,” said Abhijit Dubey, Chief Executive Officer, NTT DATA, Inc. “In supporting and driving this next era, NTT DATA feels an acute responsibility to our clients, our people and society to ensure that everything we design, implement, deploy and manage is highly resilient, capable and responsible.”

About the Report

NTT DATA commissioned Jigsaw Research to conduct primary research during late September and early October 2024. The team surveyed leaders from organizations in 34 countries across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. 98% of the 2,300+ respondents have direct authority or influence over GenAI purchase decisions.

The represented industries are Banking and Investment (11%); Insurance (9%); Manufacturing (14%); Automotive (8%); Logistics, Travel and Transportation (5%); Telco, Media and Technology (9%); Healthcare (9%); Life Sciences and Pharmaceuticals (9%); and Retail and Consumer Packaged Goods (5%); Public Sector (8%); Energy and Utilities (7%); Higher Education and Research (6%).

Learn more about NTT DATA’s GenAI services and download the full report.

About NTT DATA

NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. Visit us at nttdata.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20241114975693/en/

Contacts

NTT DATA Group Corporation
Global Innovation Headquarters
Generative AI Office
Kimbara, Morino, Takeda
Email: gai-office@hml.nttdata.co.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Only 7% of Companies Achieve Full Compliance as Global Expansion Increases Legal Complexity11.5.2026 16:00:00 EEST | Press release

As businesses accelerate their global expansion in 2026, compliance fails to keep pace. In fact, only 7% of organizations report full compliance across their global entities, according to a new study by CSC, the leading provider of global business administration and compliance solutions. CSC surveyed 350 general counsel (GCs) and senior legal professionals across Europe, North America, and Asia Pacific to examine how their teams navigate international expansion, regulatory pressure, and the increasing adoption of artificial intelligence (AI).¹ The findings appear in CSC’s latest report, General Counsel Barometer 2026: From Complexity to Control. Most organizations report partial compliance, with over half (53%) estimating they are 50–75% compliant, and a further 35% placing themselves between 76%–99%. This leaves just 7% of organizations reporting full compliance across all global entities. GCs also report low confidence in addressing ongoing demands amid global expansion. More than tw

IFF Opens Vanilla Innovation Center in Madagascar11.5.2026 15:15:00 EEST | Press release

IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health & bioscience—today announced the opening of its Vanilla Innovation Center in Madagascar, reinforcing vanilla as a strategic and priority tonality for IFF and strengthening its ability to innovate at origin. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260508110162/en/ IFF's Vanilla Innovation Center in Madagascar “The opening of the center marks an important step in how we approach vanilla innovation,” said Adam Jańczuk, Ph.D., senior vice president, research, creation and design, Taste, IFF. “By strengthening our presence at origin, we connect science, creativity and sustainability more closely, responding to climate changes, safeguarding quality and creating value across the supply chain.” Located in Toamasina, Madagascar’s principal seaport, near vanilla growing areas and post‑harvest processing activities, the 650‑square‑meter center bring

ARIS Recognised as a Leader in Gartner ® Magic Quadrant™ for Process Intelligence Platforms, Believes This Reinforces Its Role in Enabling Enterprise AI at Scale11.5.2026 15:00:00 EEST | Press release

ARIS, the process context foundation platform for enterprise AI deployment, today announced its recognition as a Leader in the Gartner® Magic Quadrant™ for Process Intelligence Platforms. This is the fourth consecutive year that ARIS has been recognized as a Leader in the report and the company believes it underscores a continued commitment to innovation and growth as enterprises focus on turning AI ambition into measurable business outcomes. While technology has advanced rapidly, companies are struggling to operationalise AI across complex operating models. ARIS sees this recognition by Gartner as a reflection of its strength in delivering a single unified platform for process intelligence, providing the context layer on which G2000 organisations can successfully deploy and scale agentic AI. “AI is moving from experimentation to execution – but many enterprises are finding it difficult to scale,” said Guillaume Bacuvier, CEO of ARIS. “The reason is simple: AI lacks the context it need

Logistics Reply Named a Visionary in 2026 Gartner® Magic Quadrant™ for Warehouse Management Systems and Ranks #2 for Level 2 and #3 for Level 3 Operations Use Cases in Gartner® Critical Capabilities Report11.5.2026 15:00:00 EEST | Press release

Logistics Reply, the Reply Group company specializing in innovative solutions for supply chain execution, is proud to announce its recognition as a Visionary in the Gartner® Magic Quadrant™ for Warehouse Management Systems for the seventh consecutive year, as its global team of warehouse technology professionals continues to drive innovation that puts customers first. Additionally, Logistics Reply for its LEA Reply™ WMS is recognized in the 2026 Gartner® Critical Capabilities for Warehouse Management Systems report where it ranked #2 for Level 2 Warehouse Operations and #3 for Level 3 Warehouse Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511344452/en/ We believe these important recognitions underscore Logistics Reply's commitment to delivering intelligent, flexible and scalable warehouse execution solutions for enterprise customers around the world. For us, our placement in the Visionaries Quadrant reflects

HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors11.5.2026 15:00:00 EEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking authorization to expand the use of its Edison® Histotripsy System to include the destruction of kidney (renal) tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511268688/en/ HistoSonics Edison® Histotripsy System This milestone marks a significant step forward in the company’s mission to transform the treatment of solid tumors with a completely non-invasive technology that harnesses focused ultrasound to mechanically liquefy and destroy targeted tissue, reducing the risk of many complications and side effects associated with surgery, radiation, and other common therapies. “This submission is an important milestone in expanding histotripsy beyond the liver and into the kidney, an area where patients and physicians are s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye